SAHA
Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
What SAHA Means in Everyday Medical Language
SAHA stands for suberoylanilide hydroxamic acid, which is also known by the drug names vorinostat and Zolinza. It is a type of medicine used to treat cancer, specifically a kind of skin lymphoma called cutaneous T-cell lymphoma. SAHA works by blocking certain enzymes called histone deacetylases (HDACs). These enzymes help cancer cells grow and divide, so by blocking them, SAHA may help stop or slow the cancer.
Why SAHA Can Matter in Cancer Care
SAHA is important because it offers a treatment option for people whose cutaneous T-cell lymphoma has not improved or has come back after other treatments. It is approved by the U.S. Food and Drug Administration (FDA) for this use. Beyond this, SAHA is being studied in clinical trials to see if it can help treat other types of cancer. This means it might become useful for more patients in the future, but its use outside of approved treatments is still being researched.
What Patients Might See or Hear About SAHA
Patients may hear the term SAHA, vorinostat, or Zolinza during discussions about treatment options, in medical reports, or when reviewing clinical trial information. Because these names all refer to the same drug, it can be confusing. Patients might also see SAHA mentioned in test results or treatment plans. It’s important to ask the healthcare team what the term means in the specific context of their care.
Where SAHA Might Appear in Medical Information
SAHA can appear in various places such as medical records, treatment plans, drug information sheets, or clinical trial listings. It may be listed under any of its names—SAHA, suberoylanilide hydroxamic acid, vorinostat, or Zolinza. When reading about SAHA, it’s helpful to compare these names to avoid confusion and to understand how it relates to the patient’s care.
What SAHA Does Not Automatically Mean
Seeing the term SAHA does not mean a patient has a diagnosis or that a specific treatment is recommended. It is simply the name of a drug that may be part of a treatment plan. Whether SAHA is right or safe for a particular person depends on many factors that only a healthcare provider can evaluate.
Common Questions to Ask Your Care Team
If SAHA comes up in your care, you might ask: What is SAHA, and how does it work? Is SAHA part of my treatment plan? What are the possible benefits and side effects? Are there clinical trials involving SAHA that I might consider? How will we know if SAHA is working? These questions can help you understand your care better.
How to Read SAHA in Context
Because SAHA has several names and is used in different ways, it’s important to look at the full context—such as the type of cancer, treatment history, and current plan—when you see this term. Don’t rely on the word alone to make decisions or assumptions. Always discuss what it means for you with your healthcare team.
Safety and Next Steps
This information about SAHA is educational and does not replace medical advice. Only your healthcare provider can decide if SAHA is appropriate and safe for you. If you see SAHA mentioned in your medical records or hear about it in your care, the best next step is to ask your care team to explain what it means for your specific situation and treatment options.
Sources
Public source information used for this glossary entry includes: